An observational study in ICD Shock Myocardial Injuries, sponsored by Monaldi Hospital. Status unknown at 1 site in Italy. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2018-03-08.
Sponsored by Monaldi Hospital · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 13 studies in Shock with a site in Italy — 1 open to participants now, 2 under way, none of them phase 3. Shock · Italy.
Among the 13 studies in Shock with a site in Italy, this one is one of 2 that started in 2018, is one of 6 observational ones, and was the 6th registered.
487 studies on the registry are indexed under Shock; 107 are open to participants now.
Browse Shock studies →1 of the 13 studies in Shock with a site in Italy is open now. Recruiting first, the newest first:
Università Vita-Salute San Raffaele · Sites in Italy, Croatia
Ages 18+
A study can be open while its sites in Italy have not opened yet or have stopped. Only those recruiting at a site in Italy →
Of the 68 Shock studies recruiting now, 52 (76%) set no upper age limit and 11 (16%) stop at 75 or younger; 9 take children under 18; 4 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
13 studies; the count open now beside each. This study's row is marked.
First in 2008; this study’s year is marked. 2 started in 2018.
This study's planned enrollment of 100 is close to the median of 100 across 247 observational studies indexed under Shock.
Median enrollment 56 across the 7 interventional studies, 501 across the 6 observational. Of the 8 that completed or were terminated, 2 (25%) have results posted.
This tab as a report to print or save as PDF → With an account.
3 of 13 have an industry lead sponsor. The 10 most frequent:
Monaldi Hospital is the lead sponsor of 7 studies on the registry; 1 is open to participants now.
Monaldi Hospital has 1 study filed under Shock — fewer than ten, so there is no comparison to draw.
1 of the studies in Shock with a site in Italy that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05898126Università Vita-Salute San RaffaeleRenin-guided Hemodynamic Management in Patients With Shock | 2027-04-28 |
Add it to your calendar (.ics) → With an account.
Among the 13 studies in Shock with a site in Italy, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Implantable cardioverter defibrillator (ICD) shocks are associated with a subsequent increased risk of death, and an elevation of cardiac enzymes has been measured after defibrillation testing (DFT). The aim of our study was to investigate the association between S-ICD vs T-ICD shocks and acute cardiac damage in humans, as evaluated by means of sensitive and highly specific circulating biomarkers
patients who met the criteria for ICD implantation according to the current guidelines
patients who met the criteria for ICD implantation according to the current guidelines
Exclusion Criteria:
-
Device: ICD
Device: ICD
Implantable Cardioverter Defibrillator
myocardial micro-damage
degree of myocardial micro-damage, assessed by calculating the variation in the serum levels of high-sensitivity cardiac troponin I (hs-CTnI) and creatine kinase-MB mass concentration (CK-MB mass), measured before and after an S-ICD shock delivered during intraoperative DFT
Time frame: 6 months
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for Apr 2018; primary completion for Sep 2018, 5 months later.
Of 120 non-industry observational studies under Shock, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 52. This study's planned 5 months is below that.
Counting every sponsor, half of 127 studies reached it within 26 months; a quarter within 12 and three quarters within 52.
How these figures are worked out, and which studies are left out of them.
This study is status unknown, as verified in Mar 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Monaldi Hospital